Back to Search
Start Over
Hyperpigmentation after Foamed Bleomycin Sclerotherapy for Vascular Malformations
- Source :
- Journal of Vascular and Interventional Radiology. 30:1438-1442
- Publication Year :
- 2019
- Publisher :
- Elsevier BV, 2019.
-
Abstract
- The present report documents 6 patients who developed distinctive hyperpigmented skin lesions after bleomycin sclerotherapy for vascular malformations of the face, neck, and extremities. The patients ranged in age from 2 to 65 years and included both black and white and male and female patients. The bleomycin treatment dose varied from 15 to 45 U, with 5 of the 6 patients receiving foamed bleomycin. The hyperpigmented lesions were near the patient's vascular anomaly and attributable to postprocedural cutaneous pressure (eg, electrocardiographic [ECG] leads or tape). Hyperpigmentation faded slowly over time but was visible up to 3 years after the procedure.
- Subjects :
- medicine.medical_specialty
business.industry
medicine.medical_treatment
Treatment outcome
Hyperpigmented skin
medicine.disease
Bleomycin
Dermatology
Hyperpigmentation
030218 nuclear medicine & medical imaging
Vascular anomaly
03 medical and health sciences
chemistry.chemical_compound
0302 clinical medicine
Treatment dose
chemistry
030220 oncology & carcinogenesis
Female patient
medicine
Sclerotherapy
Radiology, Nuclear Medicine and imaging
medicine.symptom
Cardiology and Cardiovascular Medicine
business
Subjects
Details
- ISSN :
- 10510443
- Volume :
- 30
- Database :
- OpenAIRE
- Journal :
- Journal of Vascular and Interventional Radiology
- Accession number :
- edsair.doi...........fad0afeb31381502d0e96f96a551f9ed